Supplementary Appendix S1 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
John A. Ligon(University of Florida Health), John Glod(Rutgers, The State University of New Jersey), Mary Frances Wedekind(National Cancer Institute), Amanda Carbonell(National Cancer Institute), Michael I. Barbato(United States Food and Drug Administration), Xia Xu(Leidos (United States)), Josquin Moraly(Inserm), Haiyan Lei(National Cancer Institute), Cody J. Peer(National Institutes of Health), Paul S. Meltzer(National Human Genome Research Institute), Markku Miettinen(National Cancer Institute), Jaydira Del Rivero(National Institutes of Health), King C. Chan(Leidos (United States)), Ramaprasad Srinivasan(National Institutes of Health), R. Taylor Sundby(National Cancer Institute), Seth M. Steinberg(National Cancer Institute), Richard Piekarz(Yeshiva University), Þorkell Andrésson(deCODE Genetics (Iceland)), Sara Zimmerman(National Institutes of Health), Eva Dombi(Cincinnati Children's Hospital Medical Center), Lee J. Helman(National Cancer Institute), Karel Pacák(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Brigitte C. Widemann(Cincinnati Children's Hospital Medical Center), William D. Figg(National Cancer Institute), Melissa Spencer(National Cancer Institute), Fernanda I. Arnaldez(MacroGenics (United States)), Lori Wiener(Center for Cancer Research), Stephen Fox(Leidos (United States)), W. Marston Linehan(National Cancer Institute), Jonathan Keith Killian(GlobalFoundries (United States)), John Shern(National Cancer Institute), Naomi Taylor(Institut de Génétique Moléculaire de Montpellier)
Cited by 0
Related Papers
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Cushing’s Syndrome Due to Ectopic Corticotropin Secretion: Twenty Years’ Experience at the National Institutes of Health
|The Journal of Clinical Endocrinology & Metabolism|2005|711
Somatic<i>HIF2A</i>Gain-of-Function Mutations in Paraganglioma with Polycythemia
|New England Journal of Medicine|2012|391
Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer
|Clinical Cancer Research|2005|371